[HTML] sciencedirect.com

[HTML][HTML] N6-methyladenosine (m6A) in cancer therapeutic resistance: potential mechanisms and clinical implications

D Wang, Y Zhang, Q Li, A Zhang, J Xu, Y Li, W Li… - Biomedicine & …, 2023 - Elsevier
Cancer therapy resistance (CTR) is the development of cancer resistance to multiple
therapeutic strategies, which severely affects clinical response and leads to cancer …
被引用次数：7 相关文章

N6-methyladenosine (m6A) in cancer therapeutic resistance: Potential mechanisms and clinical implications.

D Wang, Y Zhang, Q Li, A Zhang, J Xu, Y Li… - Biomedicine & …, 2023 - europepmc.org
Cancer therapy resistance (CTR) is the development of cancer resistance to multiple
therapeutic strategies, which severely affects clinical response and leads to cancer …

N6-methyladenosine (m6A) in cancer therapeutic resistance: Potential mechanisms and clinical implications

D Wang, Y Zhang, Q Li, A Zhang, J Xu… - Biomedicine & … - pubmed.ncbi.nlm.nih.gov
Cancer therapy resistance (CTR) is the development of cancer resistance to multiple
therapeutic strategies, which severely affects clinical response and leads to cancer …